Rhythm Pharmaceuticals Inc (1RV)

Currency in EUR
75.0000
+2.5000(+3.45%)
Delayed Data·
1RV Scorecard
Full Analysis
Impressive gross profit margins
1RV is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
73.500075.0000
52 wk Range
38.600078.5000
Key Statistics
Bid/Ask
74.50 / 75.50
Prev. Close
72.5
Open
73.5
Day's Range
73.5-75
52 wk Range
38.6-78.5
Volume
-
Average Volume (3m)
30
1-Year Change
61.83%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1RV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock price movements are quite volatile
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Rhythm Pharmaceuticals Inc Company Profile

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company’s lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; joint research collaboration with Axovia Therapeutics for developing in bardet-biedl syndrome; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. The company was founded in 2008 and is headquartered in Boston, Massachusetts.

Employees
283
Market
Germany

Compare 1RV to Peers and Sector

Metrics to compare
1RV
Peers
Sector
Relationship
P/E Ratio
−32.3x−1.7x−0.5x
PEG Ratio
−0.80−0.010.00
Price/Book
296.7x2.4x2.6x
Price / LTM Sales
41.1x40.0x3.2x
Upside (Analyst Target)
-320.2%42.0%
Fair Value Upside
Unlock35.4%6.6%Unlock

Earnings

Latest Release
May 07, 2025
EPS / Forecast
-0.81 / --
Revenue / Forecast
32.70M / --
EPS Revisions
Last 90 days

1RV Income Statement

People Also Watch

267.05
AVAV
-0.50%
114.42
CRDO
+4.61%
45.650
RKLB
+4.25%
61.37
MP
+1.84%
50.560
SMR
+3.25%

FAQ

What Stock Exchange Does Rhythm Pharmaceuticals Inc Trade On?

Rhythm Pharmaceuticals Inc is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Rhythm Pharmaceuticals Inc?

The stock symbol for Rhythm Pharmaceuticals Inc is "1RV."

What Is the Rhythm Pharmaceuticals Inc Market Cap?

As of today, Rhythm Pharmaceuticals Inc market cap is 4.94B.

What Is Rhythm Pharmaceuticals Inc's Earnings Per Share (TTM)?

The Rhythm Pharmaceuticals Inc EPS (TTM) is -2.82.

From a Technical Analysis Perspective, Is 1RV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Rhythm Pharmaceuticals Inc Stock Split?

Rhythm Pharmaceuticals Inc has split 0 times.

How Many Employees Does Rhythm Pharmaceuticals Inc Have?

Rhythm Pharmaceuticals Inc has 283 employees.

What is the current trading status of Rhythm Pharmaceuticals Inc (1RV)?

As of 30 Jul 2025, Rhythm Pharmaceuticals Inc (1RV) is trading at a price of 75.00, with a previous close of 72.50. The stock has fluctuated within a day range of 73.50 to 75.00, while its 52-week range spans from 38.60 to 78.50.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.